<p>在過去三個月中，5 位分析師對 Chemours（紐約證券交易所代碼：CC）的評級展示了看漲和看跌的混合觀點。</p>
<p>下表提供了分析師最近評級的簡明概述，展示了過去 30 天情緒的變化，並與前幾個月進行比較，以提供全面的視角。</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看漲</strong></th>
<th align="right"><strong>稍微看漲</strong></th>
<th align="right"><strong>無所謂</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>總評級</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>過去 30 天</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 個月前</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>分析師通過對 12 個月價格目標的評估提供了更深入的見解，顯示出平均目標為 17.4 美元，最高預估為 21.00 美元，最低預估為 13.00 美元。當前平均目標較之前的 18.80 美元下降了 7.45%。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769000466_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="價格目標圖表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769000466_0.png"/></p>
<h2>分析師評級探討：深入概述</h2>
<p>對金融專家如何看待 Chemours 的全面審查源於最近的分析師行動。以下是關鍵分析師的詳細總結，包括他們的近期評估以及對評級和價格目標的調整。</p>
<table>
<thead>
<tr>
<th>分析師</th>
<th>分析師公司</th>
<th>採取的行動</th>
<th>評級</th>
<th>當前價格目標</th>
<th>之前價格目標</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>上調</td>
<td>買入</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>下調</td>
<td>中性</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>下調</td>
<td>買入</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>下調</td>
<td>買入</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>下調</td>
<td>超過大盤</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<h3>關鍵見解：</h3>
<ul>
<li><strong>採取的行動：</strong> 分析師根據市場條件和公司表現調整他們的建議。無論是 “維持”、“上調” 還是 “下調” 他們的立場，反映了他們對 Chemours 近期發展的反應。這些信息提供了分析師對公司當前狀態的快照。</li>
<li><strong>評級：</strong> 分析師揭示了對股票的定性評估，範圍從 “超過大盤” 到 “低於大盤”。這些評級提供了 Chemours 相對於更廣泛市場的表現預期的見解。</li>
<li><strong>價格目標：</strong> 分析師在價格目標的調整中提供了 Chemours 未來價值的估計。比較當前和之前的目標提供了分析師不斷變化的預期的見解。</li>
</ul>
<p>將這些分析師評估與關鍵財務指標結合起來，可以提供 Chemours 市場地位的全面概述。保持信息靈通，並在我們的評級表的幫助下做出明智的決策。</p>
<p>隨時瞭解 Chemours 的分析師評級。</p>
<h2>深入瞭解 Chemours 的背景</h2>
<p>Chemours 公司是一家化學品供應商。它為包括塗料、塑料、製冷、空調等在內的多個市場提供廣泛的工業和特種化學品產品的定製解決方案。公司的運營部門包括鈦技術、熱能與特種解決方案以及先進性能材料。它的最大收入來自鈦技術部門。鈦技術部門是 TiO2 顏料的生產商，這是一種優質白色顏料，用於在各種應用中提供白度、亮度、不透明度、耐用性、效率和保護。從地理上看，公司大部分收入來自北美。</p>
<h3>Chemours：深入財務</h3>
<p><strong>市值：</strong> 超過行業標準，公司市值相對於同行處於行業平均水平之上。這強調了其顯著的規模和強大的市場地位。</p>
<p><strong>收入下降：</strong> 在過去 3 個月中，Chemours 面臨挑戰，導致截至 2025 年 9 月 30 日收入增長約下降 <strong>-0.86%</strong>。這意味着公司的頂線收益減少。與同行相比，收入增長落後於行業同行。公司在材料行業的增長率低於同行的平均水平。</p>
<p><strong>淨利潤率：</strong> Chemours 的淨利潤率令人印象深刻，超過行業平均水平。公司淨利潤率為 <strong>4.01%</strong>，顯示出強大的盈利能力和有效的成本管理。</p>
<p><strong>股本回報率（ROE）：</strong> Chemours 的 ROE 表現突出，超過行業平均水平。公司 ROE 為 <strong>22.43%</strong>，顯示出有效利用股本和強大的財務表現。</p>
<p><strong>資產回報率（ROA）：</strong> Chemours 的 ROA 超越行業基準，達到 <strong>0.8%</strong>。這表明資產管理高效，財務健康狀況良好。</p>
<p><strong>債務管理：</strong> Chemours 的債務與股本比率顯著高於行業平均水平，達到 <strong>14.82</strong>。這表明對借款資金的依賴較重，增加了財務槓桿的擔憂。</p>
<h2>分析師評級是如何確定的？</h2>
<p>分析師評級作為股票表現的重要指標，由銀行和金融系統的專家提供。這些專家認真分析公司的財務報表，參與電話會議，並與內部人士交流，以生成個別股票的季度評級。</p>
<p>一些分析師發佈他們對增長預估、收益和收入等指標的預測，以提供額外的指導。在使用分析師評級時，重要的是要記住，股票和行業分析師也是人，他們只是向投資者提供他們的意見。</p>
<p>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</p>

<p>Chemours（紐約證券交易所代碼：CC）在過去三個月內獲得了 5 位分析師的混合評級，12 個月的平均目標價為 17.4 美元，較之前的 18.8 美元有所下降。最近的評估顯示出從看漲到看跌的情緒範圍。主要分析師包括 Peter Osterland（Truist Securities）將目標價上調至 21.00 美元，而 Jeffrey Zekauskas（JP Morgan）則將其下調至 13.00 美元。Chemours 面臨約-0.86% 的收入下降，淨利潤率為 4.01%，股本回報率（ROE）為 22.43%，但 14.82 的高負債權益比引發了對財務槓桿的擔憂</p>

<p>Ratings for Chemours (NYSE: CC) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<div class="lb-trans"><p>在過去三個月中，5 位分析師對 Chemours（紐約證券交易所代碼：CC）的評級展示了看漲和看跌的混合觀點。</p>
</div><p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<div class="lb-trans"><p>下表提供了分析師最近評級的簡明概述，展示了過去 30 天情緒的變化，並與前幾個月進行比較，以提供全面的視角。</p>
</div><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看漲</strong></th>
<th align="right"><strong>稍微看漲</strong></th>
<th align="right"><strong>無所謂</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>總評級</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>過去 30 天</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 個月前</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</div><p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $17.4, a high estimate of $21.00, and a low estimate of $13.00. Experiencing a 7.45% decline, the current average is now lower than the previous average price target of $18.80.</p>
<div class="lb-trans"><p>分析師通過對 12 個月價格目標的評估提供了更深入的見解，顯示出平均目標為 17.4 美元，最高預估為 21.00 美元，最低預估為 13.00 美元。當前平均目標較之前的 18.80 美元下降了 7.45%。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769000466_0.png" alt="price target chart" original-src="https://www.benzinga.com/files/images/story/2026/1769000466_0.png"/></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<div class="lb-trans"><h2>分析師評級探討：深入概述</h2>
</div><p>A comprehensive examination of how financial experts perceive Chemours is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<div class="lb-trans"><p>對金融專家如何看待 Chemours 的全面審查源於最近的分析師行動。以下是關鍵分析師的詳細總結，包括他們的近期評估以及對評級和價格目標的調整。</p>
</div><table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>分析師</th>
<th>分析師公司</th>
<th>採取的行動</th>
<th>評級</th>
<th>當前價格目標</th>
<th>之前價格目標</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>上調</td>
<td>買入</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>下調</td>
<td>中性</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>下調</td>
<td>買入</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>下調</td>
<td>買入</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>下調</td>
<td>超過大盤</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
</div><h3>Key Insights:</h3>
<div class="lb-trans"><h3>關鍵見解：</h3>
</div><ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Chemours. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Chemours compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Chemours's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>採取的行動：</strong> 分析師根據市場條件和公司表現調整他們的建議。無論是 “維持”、“上調” 還是 “下調” 他們的立場，反映了他們對 Chemours 近期發展的反應。這些信息提供了分析師對公司當前狀態的快照。</li>
<li><strong>評級：</strong> 分析師揭示了對股票的定性評估，範圍從 “超過大盤” 到 “低於大盤”。這些評級提供了 Chemours 相對於更廣泛市場的表現預期的見解。</li>
<li><strong>價格目標：</strong> 分析師在價格目標的調整中提供了 Chemours 未來價值的估計。比較當前和之前的目標提供了分析師不斷變化的預期的見解。</li>
</ul>
</div><p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Chemours's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<div class="lb-trans"><p>將這些分析師評估與關鍵財務指標結合起來，可以提供 Chemours 市場地位的全面概述。保持信息靈通，並在我們的評級表的幫助下做出明智的決策。</p>
</div><p>Stay up to date on Chemours analyst ratings.</p>
<div class="lb-trans"><p>隨時瞭解 Chemours 的分析師評級。</p>
</div><h2>Delving into Chemours's Background</h2>
<div class="lb-trans"><h2>深入瞭解 Chemours 的背景</h2>
</div><p>The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal &amp; Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.</p>
<div class="lb-trans"><p>Chemours 公司是一家化學品供應商。它為包括塗料、塑料、製冷、空調等在內的多個市場提供廣泛的工業和特種化學品產品的定製解決方案。公司的運營部門包括鈦技術、熱能與特種解決方案以及先進性能材料。它的最大收入來自鈦技術部門。鈦技術部門是 TiO2 顏料的生產商，這是一種優質白色顏料，用於在各種應用中提供白度、亮度、不透明度、耐用性、效率和保護。從地理上看，公司大部分收入來自北美。</p>
</div><h3>Chemours: Delving into Financials</h3>
<div class="lb-trans"><h3>Chemours：深入財務</h3>
</div><p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<div class="lb-trans"><p><strong>市值：</strong> 超過行業標準，公司市值相對於同行處於行業平均水平之上。這強調了其顯著的規模和強大的市場地位。</p>
</div><p><strong>Decline in Revenue:</strong> Over the 3M period, Chemours faced challenges, resulting in a decline of approximately <strong>-0.86%</strong> in revenue growth as of 30 September, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.</p>
<div class="lb-trans"><p><strong>收入下降：</strong> 在過去 3 個月中，Chemours 面臨挑戰，導致截至 2025 年 9 月 30 日收入增長約下降 <strong>-0.86%</strong>。這意味着公司的頂線收益減少。與同行相比，收入增長落後於行業同行。公司在材料行業的增長率低於同行的平均水平。</p>
</div><p><strong>Net Margin:</strong> Chemours's net margin is impressive, surpassing industry averages. With a net margin of <strong>4.01%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<div class="lb-trans"><p><strong>淨利潤率：</strong> Chemours 的淨利潤率令人印象深刻，超過行業平均水平。公司淨利潤率為 <strong>4.01%</strong>，顯示出強大的盈利能力和有效的成本管理。</p>
</div><p><strong>Return on Equity (ROE):</strong> Chemours's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>22.43%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<div class="lb-trans"><p><strong>股本回報率（ROE）：</strong> Chemours 的 ROE 表現突出，超過行業平均水平。公司 ROE 為 <strong>22.43%</strong>，顯示出有效利用股本和強大的財務表現。</p>
</div><p><strong>Return on Assets (ROA):</strong> Chemours's ROA excels beyond industry benchmarks, reaching <strong>0.8%</strong>. This signifies efficient management of assets and strong financial health.</p>
<div class="lb-trans"><p><strong>資產回報率（ROA）：</strong> Chemours 的 ROA 超越行業基準，達到 <strong>0.8%</strong>。這表明資產管理高效，財務健康狀況良好。</p>
</div><p><strong>Debt Management:</strong> Chemours's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>14.82</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<div class="lb-trans"><p><strong>債務管理：</strong> Chemours 的債務與股本比率顯著高於行業平均水平，達到 <strong>14.82</strong>。這表明對借款資金的依賴較重，增加了財務槓桿的擔憂。</p>
</div><h2>How Are Analyst Ratings Determined?</h2>
<div class="lb-trans"><h2>分析師評級是如何確定的？</h2>
</div><p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<div class="lb-trans"><p>分析師評級作為股票表現的重要指標，由銀行和金融系統的專家提供。這些專家認真分析公司的財務報表，參與電話會議，並與內部人士交流，以生成個別股票的季度評級。</p>
</div><p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<div class="lb-trans"><p>一些分析師發佈他們對增長預估、收益和收入等指標的預測，以提供額外的指導。在使用分析師評級時，重要的是要記住，股票和行業分析師也是人，他們只是向投資者提供他們的意見。</p>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</p>
</div>

通過五位分析師的視角，瞭解對 Chemours 的專家展望